These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 36147402)

  • 1. The diagnostic utility of rheumatoid factor and anticitrullinated protein antibody for rheumatoid arthritis in the Indian population.
    Kumar A; Vasdev V; Patnaik SK; Bhatt S; Singh R; Bhayana A; Hegde A; Kumar A
    Med J Armed Forces India; 2022 Sep; 78(Suppl 1):S69-S74. PubMed ID: 36147402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Performance characteristics of rheumatoid factor and anti-cyclic citrullinated peptide antibody assays may impact ACR/EULAR classification of rheumatoid arthritis.
    Van Hoovels L; Jacobs J; Vander Cruyssen B; Van den Bremt S; Verschueren P; Bossuyt X
    Ann Rheum Dis; 2018 May; 77(5):667-677. PubMed ID: 29363510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence and predictive value of high-positive rheumatoid factor and anti-citrullinated protein antibody levels in nonarthritic patients with chronic hepatitis C infection.
    Lin KM; Chen WM; Tung SY; Wei KL; Shen CH; Chang TS; Chang PJ
    Int J Rheum Dis; 2019 Jan; 22(1):116-120. PubMed ID: 30338656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The value of anti-CarP and anti-PAD4 as markers of rheumatoid arthritis in ACPA/RF negative rheumatoid arthritis patients.
    Kolarz B; Ciesla M; Rosenthal AK; Dryglewska M; Majdan M
    Ther Adv Musculoskelet Dis; 2021; 13():1759720X21989868. PubMed ID: 33628335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Missing Anticitrullinated Protein Antibody Does Not Affect Short-term Outcomes in Early Inflammatory Arthritis: From the Canadian Early Arthritis Cohort.
    Shu J; Bykerk VP; Boire G; Haraoui B; Hitchon C; Thorne JC; Tin D; Keystone EC; Pope JE;
    J Rheumatol; 2015 Nov; 42(11):2023-8. PubMed ID: 26329342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of Autoantibody Isotypes Increases the Sensitivity of Serodiagnostics in Rheumatoid Arthritis.
    Sieghart D; Platzer A; Studenic P; Alasti F; Grundhuber M; Swiniarski S; Horn T; Haslacher H; Blüml S; Smolen J; Steiner G
    Front Immunol; 2018; 9():876. PubMed ID: 29740454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential response of the rheumatoid factor and anticitrullinated protein antibodies during adalimumab treatment in patients with rheumatoid arthritis.
    Bos WH; Bartelds GM; Wolbink GJ; de Koning MH; van de Stadt RJ; van Schaardenburg D; Dijkmans BA; Nurmohamed MT
    J Rheumatol; 2008 Oct; 35(10):1972-7. PubMed ID: 18785316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multicentre study to improve clinical interpretation of rheumatoid factor and anti-citrullinated protein/peptide antibodies test results.
    Van Hoovels L; Vander Cruyssen B; Sieghart D; Bonroy C; Nagy E; Pullerits R; Čučnik S; Dahle C; Heijnen I; Bernasconi L; Benkhadra F; Bogaert L; Van Den Bremt S; Van Liedekerke A; Vanheule G; Robbrecht J; Studholme L; Wirth C; Müller R; Kyburz D; Sjöwall C; Kastbom A; Ješe R; Jovancevic B; Kiss E; Jacques P; Aletaha D; Steiner G; Verschueren P; Bossuyt X
    RMD Open; 2022 Mar; 8(1):. PubMed ID: 35321875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum 14-3-3η is a novel marker that complements current serological measurements to enhance detection of patients with rheumatoid arthritis.
    Maksymowych WP; Naides SJ; Bykerk V; Siminovitch KA; van Schaardenburg D; Boers M; Landewé R; van der Heijde D; Tak PP; Genovese MC; Weinblatt ME; Keystone EC; Zhukov OS; Abolhosn RW; Popov JM; Britsemmer K; van Kuijk AW; Marotta A
    J Rheumatol; 2014 Nov; 41(11):2104-13. PubMed ID: 25128504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic utility of, and influence of tobacco usage and genetic predisposition on, immunoglobulin A, rheumatoid factor and anti-citrullinated peptide auto-antibodies in South African rheumatoid arthritis patients.
    Meyer P; Ally M; Hodkinson B; Anderson R; Tikly M
    Afr Health Sci; 2018 Jun; 18(2):295-303. PubMed ID: 30602956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of anti-citrullinated protein antibody reactivities in an inception cohort of patients with rheumatoid arthritis receiving treat-to-target therapy.
    Jonsson MK; Hensvold AH; Hansson M; Aga AB; Sexton J; Mathsson-Alm L; Cornillet M; Serre G; Lillegraven S; Fevang BS; Catrina AI; Haavardsholm EA
    Arthritis Res Ther; 2018 Jul; 20(1):146. PubMed ID: 30001740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic Accuracy of Anticarbamylated Protein Antibodies in Established Rheumatoid Arthritis: A Monocentric Cross-Sectional Study.
    Erre GL; Mundula N; Colombo E; Mangoni AA; Sechi LA; Oggiano M; Irde R; Zinellu A; Passiu G; Carru C
    ACR Open Rheumatol; 2019 Sep; 1(7):433-439. PubMed ID: 31777823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does information on novel identified autoantibodies contribute to predicting the progression from undifferentiated arthritis to rheumatoid arthritis: a study on anti-CarP antibodies as an example.
    Boeters DM; Trouw LA; van der Helm-van Mil AHM; van Steenbergen HW
    Arthritis Res Ther; 2018 May; 20(1):94. PubMed ID: 29724250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-carbamylated protein antibodies: are they useful for the diagnosis of rheumatoid arthritis?
    Ponchel F; van Delft MAM; Xie X; Burska AN; Duquenne L; Trouw LA; Emery P
    Clin Exp Rheumatol; 2021; 39(1):146-150. PubMed ID: 32662401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoantibodies to citrullinated fibrinogen compared with anti-MCV and anti-CCP2 antibodies in diagnosing rheumatoid arthritis at an early stage: data from the French ESPOIR cohort.
    Nicaise-Roland P; Nogueira L; Demattei C; de Chaisemartin L; Rincheval N; Cornillet M; Grootenboer-Mignot S; Dieudé P; Dougados M; Cantagrel A; Meyer O; Serre G; Chollet-Martin S
    Ann Rheum Dis; 2013 Mar; 72(3):357-62. PubMed ID: 22580581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of autoimmune serology test results on RA classification and diagnosis.
    Van Hoovels L; Studenic P; Sieghart D; Steiner G; Bossuyt X; Rönnelid J
    J Transl Autoimmun; 2022; 5():100142. PubMed ID: 35036891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence, sensitivity and specificity of antibodies against carbamylated proteins in a monocentric cohort of patients with rheumatoid arthritis and other autoimmune rheumatic diseases.
    Pecani A; Alessandri C; Spinelli FR; Priori R; Riccieri V; Di Franco M; Ceccarelli F; Colasanti T; Pendolino M; Mancini R; Truglia S; Barbati C; Vomero M; Sabatinelli D; Morello F; Valesini G; Conti F
    Arthritis Res Ther; 2016 Nov; 18(1):276. PubMed ID: 27887639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Only rheumatoid factor-positive subset of anti-citrullinated peptide/protein antibody-negative rheumatoid arthritis may seroconvert to anti-citrullinated peptide/protein antibody-positive.
    Hiwa R; Ohmura K; Nakabo S; Terao C; Murakami K; Nakashima R; Imura Y; Yukawa N; Yoshifuji H; Hashimoto M; Furu M; Ito H; Fujii T; Mimori T
    Int J Rheum Dis; 2017 Jun; 20(6):731-736. PubMed ID: 28198158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum anti-citrullinated protein antibodies and rheumatoid factor increase the risk of rheumatoid arthritis-related interstitial lung disease: a meta-analysis.
    Xie S; Li S; Chen B; Zhu Q; Xu L; Li F
    Clin Rheumatol; 2021 Nov; 40(11):4533-4543. PubMed ID: 34189672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of Serological Biomarkers in Rheumatoid Arthritis and Their Combination to Improve Diagnostic Performance.
    Martinez-Prat L; Nissen MJ; Lamacchia C; Bentow C; Cesana L; Roux-Lombard P; Gabay C; Mahler M
    Front Immunol; 2018; 9():1113. PubMed ID: 29928272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.